Azitra, INC DEF 14A proxy statements

Azitra, Inc. seeks shareholder approval for a massive authorized share increase, reverse stock splits, and ratification of recent private placement financing.

Azitra, Inc. urges stockholders to approve a share issuance exceeding 19.99% to Alumni Capital LP, crucial for securing an additional $1.5 million in funding and avoiding severe operational risks.

Azitra, Inc. has issued a supplement to its proxy statement, revising the voting standard for a proposal to double its authorized common stock from 100 million to 200 million shares, now requiring a majority of votes cast instead of outstanding shares.

Azitra, Inc. is holding its 2025 Annual Meeting to seek stockholder approval for key proposals including increasing authorized common stock to 200 million shares and approving an equity line of credit with Alumni Capital LP for up to $20 million, citing insufficient cash to fund operations for the next twelve months.

Azitra, Inc. has filed a definitive proxy statement with the SEC.

Azitra, Inc. is holding a special meeting of stockholders to vote on a reverse stock split proposal aimed at maintaining its listing on the NYSE American.

Azitra, Inc. is holding its 2024 Annual Meeting of Stockholders on November 20, 2024, to elect directors, approve amendments to the 2023 Stock Incentive Plan, and ratify the appointment of its independent accounting firm.

Azitra, Inc. is asking stockholders to approve a reverse stock split at its upcoming Special Meeting to maintain its listing on the NYSE American.